Folate-mediated delivery of macromolecular anticancer therapeutic agents

Area of Science:

• Oncology
• Pharmacology
• Biotechnology

Background:

• The folate receptor is upregulated in numerous human cancers, presenting a viable target for tumor-specific drug delivery.
• Its expression on the apical membrane of polarized epithelia limits access in normal tissues, enhancing tumor selectivity.
• Increased folate receptor density correlates with advanced cancer stage/grade, suggesting greater therapeutic potential in aggressive malignancies.

Purpose of the Study:

• To review the mechanistic basis of folate-targeted macromolecular therapeutics.
• To summarize the successes and failures of folate conjugation in drug delivery for various cancers.
• To explore the potential of folic acid as a targeting moiety for enhanced cancer therapy.

Main Methods:

• Conjugation of folic acid to low molecular weight drugs and macromolecular complexes.
• In vitro assessment of enhanced delivery to folate receptor-expressing cancer cells.
• In vivo evaluation of folate-mediated macromolecular targeting in solid tumors.

Main Results:

• Folic acid conjugation significantly enhanced macromolecule delivery to cancer cells in vitro.
• In vivo folate targeting yielded mixed results, primarily due to challenges in macromolecule penetration of solid tumors.
• Despite challenges, successful in vivo applications demonstrated significant improvements in macromolecule-based therapy outcomes, including complete tumor cures.

Conclusions:

• Folate receptor targeting is a promising strategy for cancer therapeutics, particularly for advanced-stage and difficult-to-treat malignancies.
• While in vitro studies show high efficacy, in vivo application requires overcoming tumor penetration barriers.
• Further research into optimizing macromolecule delivery is crucial for realizing the full therapeutic potential of folate-targeted agents.